Epithelial ovarian cancer: evolution of management in the era of precision medicine

S Lheureux, M Braunstein… - CA: a cancer journal for …, 2019 - Wiley Online Library
Ovarian cancer is the second most common cause of gynecologic cancer death in women
around the world. The outcomes are complicated, because the disease is often diagnosed …

Clinical actionability of molecular targets in endometrial cancer

ME Urick, DW Bell - Nature Reviews Cancer, 2019 - nature.com
Abstract Endometrial cancer accounts for~ 76,000 deaths among women each year
worldwide. Disease mortality and the increasing number of new diagnoses make …

[HTML][HTML] Clonal expansion and diversification of cancer-associated mutations in endometriosis and normal endometrium

K Suda, H Nakaoka, K Yoshihara, T Ishiguro, R Tamura… - Cell reports, 2018 - cell.com
Endometriosis is characterized by ectopic endometrial-like epithelium and stroma, of which
molecular characteristics remain to be fully elucidated. We sequenced 107 ovarian …

Mechanisms of PTEN loss in cancer: It's all about diversity

V Álvarez-Garcia, Y Tawil, HM Wise… - Seminars in cancer biology, 2019 - Elsevier
PTEN is a phosphatase which metabolises PIP 3, the lipid product of PI 3-Kinase, directly
opposing the activation of the oncogenic PI3K/AKT/mTOR signalling network. Accordingly …

Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma

M Köbel, AM Piskorz, S Lee, S Lui… - The Journal of …, 2016 - Wiley Online Library
TP53 mutations are ubiquitous in high‐grade serous ovarian carcinomas (HGSOC), and the
presence of TP53 mutation discriminates between high and low‐grade serous carcinomas …

The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions

MR Khezri, R Jafari, K Yousefi, NM Zolbanin - Experimental and molecular …, 2022 - Elsevier
The human body consists of countless cells with the possibility of excessive and
uncontrolled proliferation under certain dysregulated circumstances that could cause …

[HTML][HTML] Epithelial ovarian cancer

S Sambasivan - Cancer Treatment and Research Communications, 2022 - Elsevier
Epithelial ovarian cancer is the second commonest cause of death amongst all
gynaecological cancers. Treatment is challenging because almost 75% of cases are …

[HTML][HTML] Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes

BM Barnes, L Nelson, A Tighe, GJ Burghel, IH Lin… - Genome Medicine, 2021 - Springer
Background Epithelial ovarian cancer (OC) is a heterogenous disease consisting of five
major histologically distinct subtypes: high-grade serous (HGSOC), low-grade serous …

[HTML][HTML] Endometriosis: where are we and where are we going?

AD Greene, SA Lang, JA Kendziorski… - Reproduction …, 2016 - ncbi.nlm.nih.gov
Endometriosis currently affects∼ 5.5 million reproductive-aged women in the US with
symptoms such as painful periods (dysmenorrhea), chronic pelvic pain, pain with …

[HTML][HTML] Tumor evolution and chemoresistance in ovarian cancer

S Kim, Y Han, SI Kim, HS Kim, SJ Kim… - NPJ precision oncology, 2018 - nature.com
Abstract Development of novel strategies to overcome chemoresistance is central goal in
ovarian cancer research. Natural history of the cancer development and progression is …